Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrahepatic Chemotherapy for Liver Metastases
NCT01511146Phase 2Unknown
- Sponsor
- Rigshospitalet
- Start
- Jul 2011
- Primary completion
- Jul 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitomycin c, gemcitabine, oxaliplatin in solid tumor, colorectal cancer (CRC), sponsored by Rigshospitalet. Status: unknown.
02
Drugs
mitomycin cgemcitabineoxaliplatin
03
Conditions
solid tumorcolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01511146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511146.